Support & Solvents
Injection Kit
50 syringes + 100 padsEverything required to safely reconstitute and inject reconstituted peptides — 50 sterile insulin syringes plus 100 alcohol prep pads.
$25
39-AA triple agonist · LY3437943 · ~6-day half-life · Aib-substituted, C20 fatty-diacid
First-in-class triple agonist of GIP, GLP-1 and glucagon receptors — extended half-life via fatty-acid acylation.
每批次分析报告 — HPLC、ESI-MS、LAL 内毒素检测、重金属、无菌性
Buy Retatrutide 10mg at IGF1 Shop. Retatrutide, also known as 3-GLP or LY3437943, is a first-in-class synthetic 39-amino-acid peptide that simultaneously activates three metabolic receptors: GLP-1, GIP, and glucagon. This triple-agonist design is what sets Retatrutide apart from single-agonist Semaglutide and dual-agonist Tirzepatide. Strategic α-aminoisobutyric acid (Aib) substitutions confer protease resistance, and a C20 fatty diacid attached via γGlu-spacer at Lys17 produces high-affinity albumin binding with a serum half-life of approximately 6 days. Each Retatrutide 10mg vial is HPLC-verified at ≥99% purity, ESI mass-spec confirmed against the theoretical 4,731.4 Da molecular weight, and accompanied by a per-lot Certificate of Analysis. CAS 2381089-83-2.
又称: Retatrutide · 3-GLP · LY3437943 · Triple agonist peptide
Retatrutide (LY3437943, project name 3-GLP) is a 39-amino acid synthetic peptide engineered as a single-molecule agonist of three incretin and metabolic receptors simultaneously. Strategic α-aminoisobutyric acid substitutions confer protease resistance, and a C20 fatty diacid attached via γGlu-spacer at Lys17 produces high-affinity albumin binding with a serum half-life of ~6 days.
3-GLP (Retatrutide) 的每批次仅在通过反相 HPLC(220 nm 下对照参考标准品面积纯度 ≥ 99%)、ESI 质谱分子量确认及鲎变形细胞溶解物(LAL)内毒素检测(低于 0.5 EU/mg)后才予以放行。批次专属分析证书随订单提供,购买前可按需索取。